Skip to main content
Log in

Vasoconstriction in septic shock

  • What's New in Intensive Care
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. De Backer D, Donadello K, Taccone FS, Ospina-Tascon G, Salgado D, Vincent JL (2011) Microcirculatory alterations: potential mechanisms and implications for therapy. Ann Intensive Care 1:27

    Article  PubMed  PubMed Central  Google Scholar 

  2. De Backer D, Aissaoui N, Cecconi M, Chew MS, Denault A, Hajjar L, Hernandez G, Messina A, Myatra SN, Ostermann M et al (2022) How can assessing hemodynamics help to assess volume status? Intensive Care Med 48:1–13

    Article  Google Scholar 

  3. Ospina-Tascón GA, Hernandez G, Alvarez I, Calderón-Tapia LE, Manzano-Nunez R, Sánchez-Ortiz AI, Quiñones E, Ruiz-Yucuma JE, Aldana JL, Teboul JL et al (2020) Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis. Crit Care 24:52

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hamzaoui O, Jozwiak M, Geffriaud T, Sztrymf B, Prat D, Monnet X, Trouiller P, Richard C, Teboul JL (2018) Norepinephrine exerts an inotropic effect at the early phase of human septic shock. Br J Anaesth 120:517–524

    Article  CAS  PubMed  Google Scholar 

  5. Serpa Neto A, Nassar AP, Cardoso SO, Manetta JA, Pereira VG, Espósito DC, Damasceno MC, Russell JA (2012) Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care 16:R154

    Article  PubMed  PubMed Central  Google Scholar 

  6. Nagendran M, Russell JA, Walley KR, Brett SJ, Perkins GD, Hajjar L, Mason AJ, Ashby D, Gordon AC (2019) Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med 45:844–855

    Article  CAS  PubMed  Google Scholar 

  7. Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, Kashani K, Szerlip HM, Prowle JR, Bihorac A et al (2018) Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II. Crit Care Med 46:949–957

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Nakajima Y, Baudry N, Duranteau J, Vicaut E (2006) Effects of vasopressin, norepinephrine and L-arginine on intestinal microcirculation in endotoxemia. Crit Care Med 34:1752–1757

    Article  CAS  PubMed  Google Scholar 

  9. Fage N, Moretto F, Rosalba D, Shi R, Lai C, Teboul JL, Monnet X (2023) Effect on capillary refill time of volume expansion and increase of the norepinephrine dose in patients with septic shock. Crit Care 27:429

    Article  PubMed  PubMed Central  Google Scholar 

  10. De Backer D, Cecconi M, Chew MS, Hajjar L, Monnet X, Ospina-Tascón GA, Ostermann M, Pinsky MR, Vincent JL (2022) A plea for personalization of the hemodynamic management of septic shock. Crit Care 26:372

    Article  PubMed  PubMed Central  Google Scholar 

  11. De Backer D, Creteur J, Silva E, Vincent JL (2003) Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 31:1659–1667

    Article  PubMed  Google Scholar 

  12. Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, Busse LW, Altaweel L, Albertson TE, Mackey C et al (2017) Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377:419–430

    Article  CAS  PubMed  Google Scholar 

  13. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D et al (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21–30

    Article  CAS  PubMed  Google Scholar 

  14. Ospina-Tascón GA, Aldana JL, García Marín AF, Calderón-Tapia LE, Marulanda A, Escobar EP, García-Gallardo G, Orozco N, Velasco MI, Ríos E et al (2023) immediate norepinephrine in endotoxic shock: effects on regional and microcirculatory flow. Crit Care Med. 51:e157–e168

    Article  PubMed  Google Scholar 

  15. Monnet X, Lai C, Ospina-Tascon G, De Backer D (2023) Evidence for a personalized early start of norepinephrine in septic shock. Crit Care 27:322

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel De Backer.

Ethics declarations

Conflicts of interest

DDB: Edwards Lifesciences, Philips, Baxter, Viatris, Pharmazz. LH: Edwards Lifesciences. XM: Getinge, Baxter, AOL.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 109 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Backer, D., Hajjar, L. & Monnet, X. Vasoconstriction in septic shock. Intensive Care Med 50, 459–462 (2024). https://doi.org/10.1007/s00134-024-07332-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-024-07332-8

Navigation